Physician

Aaron Boyd Galbraith, M.D.

According to 2025 Medicare claims, Aaron Galbraith, M.D. (NPI: 1871835124) practices internal medicine in the Lake County, IL market, with the plurality of this provider's patient population coming from Lake, IL. This provider's primary affiliated billing organization is FROEDTERT SOUTH, INC. (NPI: 1558305284; TIN: 390816845) and primary practice location at 53158-2814.

Galbraith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 246 traditional Medicare patients, billed 2,073 HCPCS/CPT codes, and received $109,613 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 7,346 prescription claims across 481 beneficiaries totaling $1,065,338 in drug costs, led by Ozempic (Semaglutide). DME data shows 47 claims. Open Payments data shows 22 records totaling $454. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $1,837 to $109,613. Similarly, Part D prescription costs have risen steadily, from $32,656 to $1,065,338. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	13	51	$1,837
2020	N/R	N/R	N/R
2021	286	336	$14,151
2022	114	566	$38,097
2023	188	1,267	$72,537
2024	246	2,073	$109,613

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	267	$32,656
2016	207	732	$35,156
2017	668	3,972	$183,772
2018	823	7,533	$383,716
2019	871	7,691	$366,194
2020	999	9,318	$481,006
2021	911	10,125	$527,945
2022	727	3,543	$259,363
2023	346	3,553	$615,425
2024	481	7,346	$1,065,338

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	12	$354
2022	N/R	11	$757
2023	N/R	76	$4,161
2024	11	47	$6,739

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	143	143	$131
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	602	$82
99497	Advance care planning, first 30 minutes	149	149	$81
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	183	362	$12
36415	Insertion of needle into vein for collection of blood sample	148	242	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	83	4,986	$158,431
Jardiance	Empagliflozin	95	7,590	$146,289
Eliquis	Apixaban	64	4,955	$95,234
Farxiga	Dapagliflozin Propanediol	55	3,930	$70,022
Mounjaro	Tirzepatide	32	1,456	$54,351

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$6,376
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	11	20	$346
A4259	Lancets, per box of 100	N	N/R	15	$18

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	22	$454	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Boyd Galbraith, M.D.?

Tedicare shows public-source Medicare data for Aaron Boyd Galbraith, M.D. (NPI 1871835124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Boyd Galbraith, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Boyd Galbraith, M.D.?

Aaron Boyd Galbraith, M.D. is linked to FROEDTERT SOUTH, INC. (billing NPI 1558305284) in the available physician profile data.

Does Aaron Boyd Galbraith, M.D. have Open Payments data?

Aaron Boyd Galbraith, M.D. has 22 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.